
Sign up to save your podcasts
Or
In this episode of Careers in Discovery, we’re joined by Christian Schroeter, Chief Operating Officer and Managing Director at Topas Therapeutics.
Christian’s work focuses on developing immune tolerance therapies for autoimmune diseases, using nanoparticle technology to retrain the immune system. With Topas recently completing a Phase 2a trial in coeliac disease, he shares the excitement of leading a Biotech at a critical stage and the challenges of securing funding to drive the next phase of development.
He also reflects on his career journey from academia to Big Pharma and now Biotech, the lessons he’s learned from global leadership roles, and why stepping outside your comfort zone - sometimes into the “crazy” - can lead to the most rewarding opportunities.
If you're interested in the science behind immune tolerance, the transition from pharma to Biotech, and what it takes to navigate a career in life sciences, this is an episode you won’t want to miss.
4
33 ratings
In this episode of Careers in Discovery, we’re joined by Christian Schroeter, Chief Operating Officer and Managing Director at Topas Therapeutics.
Christian’s work focuses on developing immune tolerance therapies for autoimmune diseases, using nanoparticle technology to retrain the immune system. With Topas recently completing a Phase 2a trial in coeliac disease, he shares the excitement of leading a Biotech at a critical stage and the challenges of securing funding to drive the next phase of development.
He also reflects on his career journey from academia to Big Pharma and now Biotech, the lessons he’s learned from global leadership roles, and why stepping outside your comfort zone - sometimes into the “crazy” - can lead to the most rewarding opportunities.
If you're interested in the science behind immune tolerance, the transition from pharma to Biotech, and what it takes to navigate a career in life sciences, this is an episode you won’t want to miss.
86,250 Listeners
112,729 Listeners
314 Listeners
58,781 Listeners
4,740 Listeners
14,670 Listeners